Healthcare provider profile · identity verified

Daniel Lambrecht, M.D.

Internal Medicine · STERLING, CO · NPI 1083032817

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	527	149
Levothyroxine Sodium	Levothyroxine Sodium	422	107
Lisinopril	Lisinopril	371	100
Omeprazole	Omeprazole	335	85
Amlodipine Besylate	Amlodipine Besylate	307	90
Furosemide	Furosemide	197	62
Losartan Potassium	Losartan Potassium	168	43
Finasteride	Finasteride	161	40
Gabapentin	Gabapentin	159	46
Metformin Hcl	Metformin Hcl	158	47
Tamsulosin Hcl	Tamsulosin Hcl	153	47
Ozempic	Semaglutide	144	21
Metoprolol Succinate	Metoprolol Succinate	140	40
Prednisone	Prednisone	139	75
Potassium Chloride	Potassium Chloride	135	34
Pregabalin	Pregabalin	131	34
Albuterol Sulfate Hfa	Albuterol Sulfate	116	42
Hydrochlorothiazide	Hydrochlorothiazide	115	33
Metoprolol Tartrate	Metoprolol Tartrate	112	30
Oxycodone Hcl	Oxycodone Hcl	112	23
Allopurinol	Allopurinol	111	26
Linzess	Linaclotide	108	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	103	24
Tramadol Hcl	Tramadol Hcl	96	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	93	34
Simvastatin	Simvastatin	93	26
Bumetanide	Bumetanide	92	22
Carvedilol	Carvedilol	91	25
Meloxicam	Meloxicam	90	35
Glipizide	Glipizide	88	21
Xarelto	Rivaroxaban	82	16
Rosuvastatin Calcium	Rosuvastatin Calcium	79	23
Duloxetine Hcl	Duloxetine Hcl	78	25
Sertraline Hcl	Sertraline Hcl	75	16
Pantoprazole Sodium	Pantoprazole Sodium	74	21
Alprazolam	Alprazolam	68	16
Montelukast Sodium	Montelukast Sodium	65	18
Trulicity	Dulaglutide	64	11
Chlorthalidone	Chlorthalidone	63	21
Fluticasone Propionate	Fluticasone Propionate	62	27
Fentanyl	Fentanyl	60	suppressed
Metformin Hcl Er	Metformin Hcl	59	19
Citalopram Hbr	Citalopram Hydrobromide	58	17
Alendronate Sodium	Alendronate Sodium	56	16
Celecoxib	Celecoxib	55	21
Eliquis	Apixaban	55	11
Famotidine	Famotidine	55	18
Symbicort	Budesonide/Formoterol Fumarate	55	14
Warfarin Sodium	Warfarin Sodium	55	16
Spironolactone	Spironolactone	54	15
Trazodone Hcl	Trazodone Hcl	53	19
Doxycycline Hyclate	Doxycycline Hyclate	50	41
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	50	suppressed
Jardiance	Empagliflozin	49	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	47	14
Baclofen	Baclofen	46	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	16
Azithromycin	Azithromycin	43	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	17
Ropinirole Hcl	Ropinirole Hcl	43	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	42	12
Glipizide Er	Glipizide	41	suppressed
Lorazepam	Lorazepam	41	suppressed
Propranolol Hcl	Propranolol Hcl	41	suppressed
Ventolin Hfa	Albuterol Sulfate	41	suppressed
Tizanidine Hcl	Tizanidine Hcl	40	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	39	13
Clopidogrel	Clopidogrel Bisulfate	39	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	38	suppressed
Paroxetine Hcl	Paroxetine Hcl	37	suppressed
Pravastatin Sodium	Pravastatin Sodium	37	suppressed
Promethazine Hcl	Promethazine Hcl	37	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	34	11
Spiriva Respimat	Tiotropium Bromide	32	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	27
Buprenorphine	Buprenorphine	31	suppressed
Clonidine Hcl	Clonidine Hcl	30	suppressed
Ipratropium Bromide	Ipratropium Bromide	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	20
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	29	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Verapamil Er	Verapamil Hcl	28	suppressed
Levofloxacin	Levofloxacin	27	24
Novolog Flexpen	Insulin Aspart	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Mounjaro	Tirzepatide	26	suppressed
Methylprednisolone	Methylprednisolone	25	24
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	16
Lidocaine	Lidocaine	24	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	23	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Naproxen	Naproxen	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Spiriva Handihaler	Tiotropium Bromide	22	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Dulera	Mometasone/Formoterol	20	suppressed
Estradiol	Estradiol	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	15
Benazepril Hcl	Benazepril Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Methenamine Hippurate	Methenamine Hippurate	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Metolazone	Metolazone	16	suppressed
Diazepam	Diazepam	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Nabumetone	Nabumetone	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Atenolol	Atenolol	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Cephalexin	Cephalexin	13	12
Ondansetron Odt	Ondansetron	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Azathioprine	Azathioprine	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Hysingla Er	Hydrocodone Bitartrate	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Misoprostol	Misoprostol	12	suppressed
Primidone	Primidone	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Sulfasalazine Dr	Sulfasalazine	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error